TEMIS Buys i3 Analytics

French semantic tagging specialist TEMIS has acquired US-based advanced analytics and visualization technology firm i3 Analytics for an undisclosed amount.

Founded in 2011, i3 Analytics provides a software-as-a-service (SaaS) 'Biopharma Navigator' platform that charts the biopharma landscape based on open life sciences data.

Through the acquisition, TEMIS will integrate i3's platform into its flagship Luxid product, which is used to semantically enrich content with domain-specific metadata, and enables publishers to package and deliver relevant information to their audience. As part of the deal, TEMIS will also roll out the i3 service across other vertical markets.

Eric Brégand (pictured), CEO of TEMIS, comments: 'This transaction creates a best-in-class offering for our life sciences customers, based on the winning combination of deep computational linguistics expertise and leading-edge data visualization know-how. And we will be transposing the solution to other verticals where data analytics and information visualization are also becoming critical.'

Web sites: www.temis.com and www.i3analytics.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.